On-Going Partnership to Develop Rapid POC Solutions

On-Going Partnership to Develop Rapid POC Solutions

Innova Biosciences and TTP have extended their R&D partnership which will enable TTP’s Desktop Biology to provide a fast route to market for companies looking to commercialise their assays. Innova is providing custom magnetic beads and alkaline phosphatase conjugation services, to support the conjugate screening phases of TTP’s assay development.

The continuing collaboration follows the success of the original custom project, under which Innova developed a range of magnetic beads of different diameters conjugated to capture antibodies. Innova were able to produce all conjugates within 1 week of receiving antibody material.

Nick Gee, CEO and CSO at Innova Biosciences, commented: “We are pleased to be supporting TTP in the development of point-of-care diagnostics. The immunodiagnostics market continues to expand worldwide, and this therefore presents an exciting opportunity for both Innova and TTP.”

Edwin Stone, at TTP plc, said: “By offering a full-service assay and hardware development solution, TTP is able to provide its clients with greatly reduced time to market. Our relationship with Innova expands and reinforces our Desktop Biology service, enabling our clients to achieve a competitive advantage.”